News

STAT2h
An AI experiment at the FDA & Novo trailing in the obesity drug race
This week on "The Readout LOUD" podcast: an AI experiment at the FDA and how Novo Nordisk is trailing in the obesity drug ...
STAT10h
Pharmalittle: We’re reading about Novo Nordisk’s cautious culture, FDA approvals, and more
In the late 2010s, Novo Nordisk shelved a weekly obesity treatment that targeted three hormones at once, though it caused notable weight loss in mice ...
Knowridge Science Report3d
New drugs could help treat obesity, diabetes—and even addiction
Most current drugs for obesity and diabetes, like liraglutide, target a hormone receptor known as GLP-1. These medications ...
Medscape10d
First-Generation Anti-Obesity Medications: Overlooked Gems for Obesity Treatment
Obesity specialists say first-generation anti-obesity medications often get a ‘bad wrap,’ but these drugs can be effective ...
The New York Sun11d
Millions of Americans Face Sticker Shock From Weight Loss Drugs as FDA Bars Production of Cheaper Versions of Ozempic, Others
Compounding pharmacies, that produced the weight loss drugs at a fraction of their brand name price, are being forced to stop ...
Opinion
Junk food is addictive. Drugs like Ozempic treat addiction. But when will we tackle Big Food like we did Big Tobacco?
A former head of the US Food and Drug Administration cut his body fat in half using GLP-1 drugs. In his book, he compares the harm of the food and tobacco industries.
What’s the Price Outlook for Weight-Loss Drugs?
The supply of GLP-1 drugs like Ozempic has been increasing, but they’re still expensive for most patients. Here are answers ...
LA Times on MSN16d
You need more than Ozempic to fight food addiction. Here’s how
In 'Diet, Drugs, and Dopamine,' former FDA Commissioner David A. Kessler offers a comprehensive guide to weight loss.
Weight-Loss Drugs Aren’t Really About Weight
Ever since the pharmaceutical company Novo Nordisk realized that GLP-1 drugs were useful for more than diabetes, doctors and ...
The Heartland Institute9d
FDA to Phase Out Synthetic Food Dyes
The U.S. Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA) plan to phase out all ...
Seattle weight loss patients fret over FDA limits on off-brand drugs
As the Food and Drug Administration clamps down on off-brand weight loss medications, Seattle-area residents are stocking up ...
Weight-loss drugs may lower cancer risk in people with diabetes, a study suggests
After four years, those who took GLP-1 drugs had a 7% lower risk of developing an obesity-related cancer and an 8% lower risk of death from any cause compared to those who took the other type of ...